| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/10/2013 | CN102600047B Preparation method for cedar leaf liquid soap |
| 04/10/2013 | CN102579351B Injection mezlocillin sodium liposome and preparation method |
| 04/10/2013 | CN102579288B Natural plant essential oil composition capable of directly serving as mosquito repellent |
| 04/10/2013 | CN102552307B Compound astragalus polysaccharide injection used for pigs and preparation method thereof |
| 04/10/2013 | CN102512358B Rifaximin vaginal suppository for livestock and preparation method for same |
| 04/10/2013 | CN102441139B Traditional Chinese medicinal enema for treating infantile dysentery |
| 04/10/2013 | CN102327273B Compound clobetasol propionate nano-medicament and preparation method thereof |
| 04/10/2013 | CN102321638B New porcine reproductive and respiratory syndrome virus ORF5 modified gene and application thereof |
| 04/10/2013 | CN102309440B Method for producing ganciclovir glucose injection |
| 04/10/2013 | CN102308898B Medicinal fresh Chinese herb tea containing Chimonanthus fragrans, and preparation method and usage thereof |
| 04/10/2013 | CN102302704B Preparation method for toxin expelling and verruca dispelling pill |
| 04/10/2013 | CN102302527B Application of Chinese gall preparation to preparation of yersinia pestis outer membrane protein H inhibitor |
| 04/10/2013 | CN102302487B Application of andrographolide C15 substituted series derivatives to preparation of medicine for resisting hepatitis B |
| 04/10/2013 | CN102283989B Chinese medicinal cataplasm preparation for treating infantile pneumonia and preparation method thereof |
| 04/10/2013 | CN102283850B Oil-in-water type compound ketoconazole nano-medicament and preparation method thereof |
| 04/10/2013 | CN102274355B Externally applied medicament for treating foot-and-mouth disease in pigs |
| 04/10/2013 | CN102274217B Application of triclosan as synergist of antifungal agent fluconazole |
| 04/10/2013 | CN102274216B Synergist for improving antifungal action of fluconazole |
| 04/10/2013 | CN102274215B Synergist with synergetic antifungal effect with fluconazole |
| 04/10/2013 | CN102242138B Recombination expression of cynoglossus semilaevis antibacterial peptide hepcidin and application thereof |
| 04/10/2013 | CN102225062B Pharmaceutical composition for treating infectious diseases caused by Acinetobacter baumannii |
| 04/10/2013 | CN102219845B Half-smooth tongue sole hepcidin antimicrobial peptide |
| 04/10/2013 | CN102144992B Bacteriostatic and bactericidal activity of phenylglycine derivatives to Staphylococcus aureus |
| 04/10/2013 | CN102140101B Method for preparing Herperione, application thereof, capsule thereof, preparation method and application of capsule |
| 04/10/2013 | CN102133213B Veterinary compound florfenicol injection and preparation method thereof |
| 04/10/2013 | CN102093376B Furocoumarin compound and application thereof |
| 04/10/2013 | CN102091067B New application of furocoumarin compound in preparing drug |
| 04/10/2013 | CN102078621B Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 04/10/2013 | CN102058878B Prosoma pellet tablet for generating allicin in stomach and preparation method thereof |
| 04/10/2013 | CN102038948B Vaccine for controlling persistent infection of hepatitis B virus |
| 04/10/2013 | CN102010425B 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/10/2013 | CN101978864B Rape bee-pollen extract and use thereof |
| 04/10/2013 | CN101967186B Encephalitis virus protein and code gene and application thereof |
| 04/10/2013 | CN101967185B Encephalitis virus protein as well as coding gene and application thereof |
| 04/10/2013 | CN101953889B Compound ceftiofur suspension emulsion injection and preparation method thereof |
| 04/10/2013 | CN101906123B 4''-aralkyl carbamic acid ester clarithomycin derivative and preparation method and application thereof |
| 04/10/2013 | CN101903353B Aminopyrazole derivatives |
| 04/10/2013 | CN101863978B Human source anti-rabies virus Fab antibody, cross linking method thereof with nanometer particles and application thereof |
| 04/10/2013 | CN101791404B Fish soaking vaccine immunity adjuvant and application and using method thereof |
| 04/10/2013 | CN101723912B 2-[5-(2-hydroxyphenyl)-1,3,4-oxadiazole-2-thioether]-1-acetophenone compounds |
| 04/10/2013 | CN101712935B Candida albicans toxicity related gene CaMSS11 and application thereof |
| 04/10/2013 | CN101712679B Acylamide class compound, medicine composition, preparation method and application thereof |
| 04/10/2013 | CN101712633B Alpha or beta-aldehyde ketone derivative, method for preparing same and activities thereof for resisting drug-resistance bacterium pathogens and helicobacter pylori |
| 04/10/2013 | CN101709056B 2-[5-(2-oxyphenyl)-1,3,4-thiadiazole-2-thioether]-1-acetophenone compound |
| 04/10/2013 | CN101703516B Tinidazole/miconazole nitrate/neomycin compound vaginal suppository and preparation method thereof |
| 04/10/2013 | CN101502553B Rhizoma atractylodis total terpene alcohol solid dispersoid, medicament composition and preparation method thereof |
| 04/09/2013 | US8415525 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 04/09/2013 | US8415399 Retrovirus-infection inhibitor |
| 04/09/2013 | US8415331 Doxycycline metal complex in a solid dosage form |
| 04/09/2013 | US8415329 Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
| 04/09/2013 | US8415322 Modified fluorinated nucleoside analogues |
| 04/09/2013 | US8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 04/09/2013 | US8415289 Bacterial-derived BLIS for treatment of acne |
| 04/09/2013 | US8415152 Therapeutical composition containing dentritic cells and use thereof |
| 04/09/2013 | US8414916 Chewable soft capsule |
| 04/09/2013 | US8414915 Dual action, inhaled formulations providing both an immediate and sustained release profile |
| 04/09/2013 | US8414900 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | US8414886 Method of treating disease |
| 04/09/2013 | CA2749172C Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 04/09/2013 | CA2656356C Antiviral phosphinate compounds |
| 04/09/2013 | CA2536436C 2-amido-4-aryloxy-1-carbonyl pyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/09/2013 | CA2531050C Pharmaceutical compounds |
| 04/09/2013 | CA2451116C Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 04/09/2013 | CA2410350C Use of lactobacillus casei in immunostimulatory compounds |
| 04/09/2013 | CA2398269C Non-immunosuppressant hiv tat |
| 04/04/2013 | WO2013049220A1 Novel vaccination strategies or therapeutic treatment for influenza virus |
| 04/04/2013 | WO2013048995A1 Compounds for the treatment of hepatitis c |
| 04/04/2013 | WO2013047846A1 Glycosylated polypeptide and pharmaceutical composition containing same |
| 04/04/2013 | WO2013047748A1 Antigen-binding molecule promoting disappearance of antigens having plurality of biological activities |
| 04/04/2013 | WO2013047530A1 Anti-fungal agent |
| 04/04/2013 | WO2013046161A1 Topical pharmaceutical compositions comprising acyclovir |
| 04/04/2013 | WO2013045491A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations. |
| 04/04/2013 | WO2013045479A1 N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate |
| 04/04/2013 | WO2013044871A1 The use of chloroquine, chlorpromazine, derivatives thereof, or mixtures thereof in preparing medications for treating and/or preventing pulmonary infection and injury |
| 04/04/2013 | WO2013044865A1 Oxazolidinone antibiotics containing fused ring |
| 04/04/2013 | WO2013044845A1 Biaryl heterocycle substituted oxazolidinon antibacterial drug |
| 04/04/2013 | WO2013044840A1 Neutralizing molecule of highly pathogenic avian influenza and preparation method therefor |
| 04/04/2013 | WO2013044811A1 Gemcitabine amide derivative and preparation method and use thereof |
| 04/04/2013 | WO2013044789A1 Low impurity content caspofungin preparation, method for preparing same, and use thereof |
| 04/04/2013 | WO2013044763A1 3-fluoro-5-(trifluoromethyl)-n-(2-(2-thienyl)ethyl)benzamide and use thereof |
| 04/04/2013 | WO2013044398A1 Chlamydia antigen compositions and uses thereof |
| 04/04/2013 | WO2013044390A1 Increasing virus-like particle yield in plants |
| 04/04/2013 | WO2013015586A9 Vaccine composition for preventing and treating colibacillosis and salmonellosis in poultry, containing a salmonella strain expressing virulence factors of pathogenic escherichia coli of poultry |
| 04/04/2013 | WO2013006688A3 N-terminal deleted gp120 immunogens |
| 04/04/2013 | WO2013006401A3 Methods and compositions of protein antigens for the diagnosis and treatment of herpes simplex viruses type 1 and 2 |
| 04/04/2013 | WO2013005698A9 Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 04/04/2013 | WO2012178127A3 Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites |
| 04/04/2013 | WO2012177020A3 Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
| 04/04/2013 | WO2012173689A3 Antimicrobial compounds and methods of making and using the same |
| 04/04/2013 | WO2012173447A3 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient |
| 04/04/2013 | WO2012118712A3 Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis c virus infection |
| 04/04/2013 | WO2012109314A3 Potent hiv inhibitors targeting ccr5 and gp41 |
| 04/04/2013 | WO2012072713A3 Lysine demethylase inhibitors such as cyclylcyclopropanamine derivatives for use in the treatment of diseases and disorders associated with flaviviridae |
| 04/04/2013 | US20130085461 Method for Pre-Debriding Treatment of Non-Viable Skin Tissue and Compositions and System Thereof |
| 04/04/2013 | US20130085262 Novel surface antigen |
| 04/04/2013 | US20130085166 Formulations and uses of retinoic acid receptor selective agonists |
| 04/04/2013 | US20130084319 Broad-spectrum antimicrobial compositions based on combinations of taurolidine and protamine and medical devices containing such compositions |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | DE102010024041A1 Eliminating excessive processes of respiratory tract, device for holding anti-emulsion for excessive processes of respiratory tract, and method for introducing anti-emulsion into mouth and into nose by index finger |